Search Results

You are looking at 131 - 140 of 1,090 items for :

  • "community" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer

Richard Li, Wei-Hsien Hou, Joseph Chao, Yanghee Woo, Scott Glaser, Arya Amini, Rebecca A. Nelson, and Yi-Jen Chen

(OR, 1.68; 95% CI, 1.43–1.99; P <.001), Charlson-Deyo comorbidity score ≥2 (OR, 1.46; 95% CI, 1.18–1.81; P <.001), treatment at community facility rather than academic (OR, 1.27; 95% CI, 1.07–1.51; P =.006), and T2 disease compared with the

Full access

What Constitutes Quality of Life? Perspectives of Adolescents and Young Adults With Advanced Cancer

Jane Hinkle, Lori Wiener, Andrea Altschuler, Katharine E. Brock, Mallory Casperson, Chun R. Chao, Lauren Fisher, Lawrence H. Kushi, Joshua R. Lakin, Anna Lefebvre, Corey M. Schwartz, Dov M. Shalman, Catherine B. Wall, and Jennifer W. Mack

. Finally, a majority of patient recruitment occurred at academic tertiary care centers whose patient populations may differ from those who seek care at community cancer centers. Further research is required to validate these findings among younger AYAs

Full access

Renal Cell Cancer: A Shift in Approaches for Treatment of Advanced Disease in the United States

Matthew P. Banegas, Linda C. Harlan, Bhupinder Mann, and K. Robin Yabroff

RCC in community practice were examined, focusing on systemic therapy. Patients and Methods Data Source and Study Sample NCI Patterns of Care Data: The NCI SEER program collects information on all cancer diagnoses in defined geographic

Full access

Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population

Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta

. Methods We identified 184 cases of primary adult HNSCC treated at an urban, community-based academic health center between March 1, 2005, and March 8, 2017. The study protocol was approved by the Institutional Review Board (IRB 2018-9739). Patients with

Full access

Role of Advocates in Research: The Research Advocate Network (RAN) as a Model for Advocate Participation

Judy Perotti, Elda Railey, Mary Lou Smith, and Cheya Pope

Full access

The Quickening Pace of Oncology Research

Rodger J. Winn

Full access

Point/Counterpoint: Early Detection of Prostate Cancer: Do the Benefits Outweigh the Consequences?

Peter R. Carroll and Andrew J. Vickers

Few clinical issues have polarized the oncology community as much as screening for prostate cancer, with advocates of prostate-specific antigen (PSA) testing vocal on one side and skeptics just as vocal on the other. At the NCCN 19th Annual Conference, Dr. Peter R. Carroll and Dr. Andrew J. Vickers tackled the controversy surrounding early detection of prostate cancer, focusing attention on the randomized trial results at the heart of the matter; over-detection (the Achilles’ heel of screening); and the rationale behind the new, streamlined 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection, which emphasize selective early detection and treatment and are tightly aligned with the NCCN Guidelines for Prostate Cancer.

Full access

Can You Recommend a Doctor for My Brother's Secretary's Sister?

Christopher E. Desch

Full access

Coverage Policy and Use Beyond the FDA-Approved Label

William T. McGivney

Full access

A Tribute to Rodger J. Winn, MD

William T. McGivney